Skip to content

FP7H2020HORIZON

Erasmus Universitair Medisch Centrum Rotterdam

Country
NLNetherlands
Defence projects
0
Projects, all programmes
406
As coordinator
129
EU contribution (CORDIS)
EUR 246,440,988
Active
2007 to 2026

Projects

406 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ARCASARCAS: Analysis of the Route to Commercialisation of MVA based influenza vaccinesFP72012CoordinatorEUR 149,840
COMBI-BIODevelopment of COMBInatorial BIOmarkers for subclinical atherosclerosisFP72012ParticipantEUR 146,887
IMPROvEDIMPROvED: IMproved Pregnancy Outcomes by Early Detection; personalized medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcomeFP72012ParticipantEUR 723,400
EUCLIDSThe genetic basis of meningococcal and other life threatening bacterial infections of childhoodFP72011ParticipantEUR 417,962
TINN2Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonatesFP72011ParticipantEUR 223,000
DDRESPONSEThe DNA damage response and breast cancerFP72011CoordinatorEUR 2,292,900
MAPPING FEAR MEMORYIdentification and selective targeting of neuronal networks underlying memoryFP72011CoordinatorEUR 169,535
SHARE_M4Multinational Advancement of Research Infrastructures on AgeingFP72011ParticipantEUR 273,928
ENS@T-CANCEREuropean Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adultsFP72011ParticipantEUR 385,000
ADITECAdvanced Immunization TechnologiesFP72011ParticipantEUR 460,000
COMMHERECommunication of European Health ResearchFP72011ParticipantEUR 462,460
BLUEPRINTA BLUEPRINT of Haematopoietic EpigenomesFP72011ParticipantEUR 252,100
MEDIAThe MEtabolic Road to DIAstolic Heart FailureFP72011ParticipantEUR 497,400
EUROCANPLATFORMA European Platform for Translational Cancer ResearchFP72011ParticipantEUR 310,200
QUIC-CONCEPTQUantitative Imaging in Cancer: CONnecting CEllular Processes with TherapyFP72011ParticipantEUR 210,000
ACTIVATION OF XCIMolecular mechanisms controlling X chromosome inactivationFP72011CoordinatorEUR 1,500,000
PHARMACHILDLong-term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulatory drugsFP72011ParticipantEUR 169,800
SAFEGUARDSafety Evaluation of Adverse Reactions in DiabetesFP72011CoordinatorEUR 566,342
ARTFORCEAdaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomEFP72011ParticipantEUR 23,706
AIDAPreserving old antibiotics for the future : assessment of clinical efficacy by a pharmacokinetic/pharmacodynamic approach to optimize effectiveness and reduce resistance for off-patent antibioticsFP72011CoordinatorEUR 657,960

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.